Motor Neurons Pathology After Chronic Exposure to MPTP in Mice

Area of Science:

• Neuroscience
• Toxicology
• Pathology

Background:

• 1-methyl,4-phenyl-1,2,3,6-tetrahydropiridine (MPTP) is a neurotoxin used to model Parkinson's disease (PD).
• Chronic MPTP exposure better mimics PD pathology than acute exposure.
• While catecholamine neurons are known targets, MPTP's spinal cord effects, including motor neuron alterations, are increasingly recognized in PD.

Purpose of the Study:

• To investigate the effects of chronic low-dose MPTP on spinal cord motor neurons and alpha-synuclein.
• To compare spinal cord pathology with dopaminergic neuron changes in MPTP-treated mice.
• To determine the relative toxic thresholds of spinal motor neurons versus nigral dopaminergic neurons.

Main Methods:

• Mice were administered MPTP (10 mg/kg daily for 21 days).
• Quantification of motor neurons in the ventral lumbar spinal cord.
• Assessment of alpha-synuclein and Calbindin D28 KDa immune-staining in the spinal cord.
• Evaluation of dopaminergic cell bodies in the Substantia Nigra and tyrosine hydroxylase in the striatum.

Main Results:

• Chronic low-dose MPTP significantly reduced spinal cord motor neurons.
• Increased alpha-synuclein immune-staining was observed in the ventral horn.
• MPTP affected other spinal neurons (Calbindin D28 KDa positive) and caused slight striatal dopaminergic changes, but minimal nigral dopaminergic neuron loss.
• The toxic threshold for spinal motor neurons appeared lower than for nigral dopaminergic neurons.

Conclusions:

• Chronic low-dose MPTP induces spinal cord pathology, including motor neuron loss and alpha-synuclein accumulation, mirroring PD.
• Spinal cord involvement in PD and MPTP-induced parkinsonism is supported by these findings.
• Motor neurons in the spinal cord may be more vulnerable to chronic MPTP intoxication than nigral dopaminergic neurons.